Results 261 to 270 of about 10,145,629 (294)
Some of the next articles are maybe not open access.
Migraine and treatment-resistant depression
2023Migraine and major depressive disorders (MDD) or treatment resistant depression (TRD) represent a significant global burden and are often comorbid, further complicating diagnosis and treatment. Epidemiological studies have demonstrated a bidirectional relationship between migraine and MDD/TRD, with patients suffering from one disorder exhibiting a ...
openaire +2 more sources
Defining treatment‐resistant depression
Depression and Anxiety, 2019Varying conceptualizations of treatment-resistant depression (TRD) have made translating research findings or systematic reviews into clinical practice guidelines challenging and inconsistent.We conducted a review for the Centers for Medicare & Medicaid Services and the Agency for Healthcare Research and Quality to clarify how experts and investigators
Bradley N. Gaynes +12 more
openaire +2 more sources
Overview of treatment-resistant depression
2023Patients with major depressive disorder (MDD) often exhibit an inadequate treatment response or failure to achieve remission following treatment with antidepressant drugs. Treatment-resistant depression (TRD) is proposed to identify this clinical scenario.
openaire +2 more sources
Rethinking the Treatment-Resistant Depression
Treatment-resistant depression (TRD) affects about one-third of people with major depression and leads to higher suicide rates, impaired functioning, and increased healthcare use. Originally defined as nonresponse to tricyclic antidepressants, TRD now encompasses inadequate response to multiple antidepressant classes, psychotherapy, and neuromodulation.Yunfei, Tan, Kenji, Hashimoto
openaire +2 more sources
Clomipramine augmentation in treatment-resistant depression
Depression and Anxiety, 1997In depression that is resistant to tricyclic antidepressant (TCA) therapy, the substitution of a selective serotonin re-uptake inhibitor (SSRI), clomipramine, or a monoamine oxidase (MAO) inhibitor has been recommended. However, adding an additional antidepressant medication from a different drug class may produce even more rapid efficacy.
J D, Amsterdam +2 more
openaire +2 more sources
TREATMENT-RESISTANT BIPOLAR DEPRESSION
Psychiatric Clinics of North America, 1996Patients with treatment-resistant bipolar depression require careful management, which takes into account the life-threatening potential of their depression and the risk of iatrogenic mania. Because there are few data specific to treatment of bipolar depression, much of the approach to bipolar depression is derived from experience with unipolar ...
openaire +2 more sources
Psilocybin for Treatment-Resistant Depression
New England Journal of Medicine, 2023Bruno, Roméo +2 more
openaire +5 more sources
Treatment-resistant depression
The Nurse PractitionerABSTRACT In 2023, the percentage of people in the US who experienced depression in their lifetime was at an all-time high of 29%. Depression causes considerable distress and functional impairment affecting quality of life, employment, and interpersonal relationships.
Leesa A, McBroom, Melissa, Timmons
openaire +2 more sources

